Japan sets a significant milestone of applying cost-effectiveness to reimbursement price assessments, indicating gr… https://t.co/vWKinK5wcB
Customer Logins
Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.
Customer Logins
Our pricing and reimbursement research presented at ISPOR Europe
14 November 2018
Milena Izmirlieva
In research, presented at the ISPOR Europe meeting in Barcelona on 13 October, Associate Director Milena Izmirlieva examines the impact of securing marketing approval under an expedited pathway on pricing and reimbursement outcomes.
Related Posts
-
-
-
-
-
-
-
-
Explore
RELATED INDUSTRIES & TOPICS
Follow Us
RT @IHSMarkit: [1/6] IHS Markit's statement on the final verdict in the murder trial of former Minneapolis police officer Derek Chauvin: #…
Vaccine hesitancy – driven by safety concerns for adenovirus-based COVID-19 vaccines – is delaying vaccine delivery… https://t.co/V6nvvKhO6G
RT @IHSMarkit: The rollercoaster of 2020 caught #globalmarkets by surprise. So, what does our team of experts expect for 2021 and beyond?…